Projects per year
Personal profile
Research Interest Keywords
- Oncology
- Health Outcomes
- Early phase clinical development
- pharmacogenetics and pharmacogenomics
- Clinical Pharmacology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 10 Reduced Inequalities -
SDG 13 Climate Action
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Overcoming Treatment Resistance in Pancreatic Cancer by Targeting Mitochondrial Glutamine and Pyruvate
Ronayne, C. T. (PI) & Stenehjem, D. D. (Co-Principal Investigator)
Whiteside Inst. for Clinical Research
1/1/26 → 12/31/26
Project: Research project
-
Real World Treatment Patterns in mPC by Hormone Sensitivity and HRRm Status
Stenehjem, D. D. (PI)
THE UNIVERSITY OF UTAH, PFIZER, INC.
12/16/25 → 12/31/26
Project: Research project
-
Steady-state pharmacokinetics of osimertinib stratified by CYP1A2 and CYP2D6 genotypes
Brown, J. T. (PI) & Stenehjem, D. D. (CoI)
Whiteside Inst. for Clinical Research
1/1/20 → 12/31/26
Project: Research project
-
Treatment patterns and outcomes of patients with metastatic pancreatic adenocarcinoma
Stenehjem, D. D. (PI)
THE UNIVERSITY OF UTAH, ASTELLAS PHARMA, INC
6/13/25 → 7/31/26
Project: Research project
-
A Phase 1 Dose-Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers
Gupta, V. K., Yoo, B., Weiss, D., Basile, F. G., Schuck, E., Rubino, C. M., Zhang, S., Maxwell, S. E., Zheng, W., Tan, J. B. L., Stenehjem, D., Watkins, P. B., Dugan, M., Yin, W., Wright, D. H., Akinsanya, K. & Lickliter, J., Jan 2026, In: Clinical Pharmacology in Drug Development. 15, 1, e70008.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States
Farrokhi, P., Park, L., Schmutz, H. W., Thompson, S. L., Lam, C., Bryan, J. & Stenehjem, D. D., Dec 2026, In: npj Breast Cancer. 12, 1, 76.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacogenomics case-based education: Establishment of an Extension for Community Health Outcomes (ECHO) education model for healthcare professionals
Jacobson, P. A., Johnson, A. N. K., Bishop, J. R., Baye, J., Petry, N. J., Bright, D. R., Brown, J. T., Long, S. E., Sorge, L., Gregornik, D. B., Kisor, D. F. & Stenehjem, D. D., Jan 15 2026, In: American Journal of Health-System Pharmacy. 83, 2, p. 102-112 11 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States
Farrokhi, P., Park, L., Schmutz, W., Thompson, S. L., Lam, C., Bryan, J. & Stenehjem, D. D., Dec 2026, In: npj Breast Cancer. 12, 1, 42.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States
Tan, C. J., Willis, C., Bell, T., Tumminello, B., Zhou, S., Doshi, D., Asche, C. V., Biskupiak, J., Brixner, D., Chalmers, A. & Stenehjem, D. D., Jan 2026, In: Cancer Research Communications. 6, 4, p. 792-802 11 p.Research output: Contribution to journal › Article › peer-review
Open Access